• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    MDB Capital Holdings Provides First Quarter 2025 Update

    5/21/25 9:00:00 AM ET
    $BEAT
    $MDBH
    Medical/Dental Instruments
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $BEAT alert in real time by email

    Addison, TX, May 21, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, today provides an update on operations through and subsequent to the quarter ended March 31, 2025.

    First Quarter 2025 and Subsequent Operational Highlights

    • Closed a public offering of common stock for HeartBeam, Inc (NASDAQ:BEAT) with gross proceeds of approximately $11.5 million.
    • Completed LOIs for 3 new "Big Idea" companies to launch in 2025.
    • Increased our MDBH shareholder base by 4.5% during Q1 2025.
    • Onboarded 111 new MDB Direct accounts during the first quarter, a 26% increase since the end of 2024.
    • Broadened our relationships with angel groups, RIAs and family offices to expand awareness and participation in public venture financings.
    • Exploring innovative new approaches to leverage our self-clearing platform to broaden our IPO offerings for early-stage and emerging companies beyond deep tech.
    • Revised executive compensation plan for four top executives to realign compensation incentives with shareholder interests.

    "Despite the market volatility and cautious investor climate, we are seeing a steady flow of micro-cap companies with really exciting technologies that want to go public but have been unable to get the right partner to get them there. During first quarter, we have continued to work on a robust pipeline of new opportunities in the final stages of diligence which will enable us to focus on scaling the number of disruptive technology ideas we turn into valuable public companies this year," said Christopher Marlett, Co-Founder and CEO of MDB Capital Holdings.  

    First Quarter 2025 Update Zoom Webinar at 4:30 p.m. ET Today

    Christopher Marlett, CEO and Co-Founder of MDB will lead the call and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period.

    Investors can pre-register now for the Zoom webinar HERE. The live webinar can also be accessed on the day of the event through MDB's investor relations website at https://investors.mdb.com/.

    About MDB Capital Holdings, LLC

    Founded in 1997, MDB Capital focuses on launching "Big Ideas" into valuable public companies with a better approach to public venture capital. This approach involves community-driven financings of pre-revenue, early-stage disruptive technology companies through early public offerings, primarily listed on NASDAQ, as well as post-IPO offerings for already public companies that fit MDB's overall criteria for investment.

    MDB Capital is the brand under which MDB Capital Holdings, LLC (NASDAQ:MDBH) and its subsidiaries operate and provide services, which includes a self-clearing broker-dealer and trading platform and an integrated, intellectual property (IP) strategy consulting and law firm. MDB Capital is a registered broker-dealer, Member FINRA/SIPC.

    For more information, please visit www.mdb.com.

    Forward-Looking Statements

    This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release.

    Investor Relations Contact:

    [email protected]

    Media Contact:

    [email protected]



    Primary Logo

    Get the next $BEAT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BEAT
    $MDBH

    CompanyDatePrice TargetRatingAnalyst
    Heartbeam Inc.
    $BEAT
    12/20/2021$9.00Speculative Buy
    Benchmark
    More analyst ratings

    $BEAT
    $MDBH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PatentVest Releases First-Ever Quantum Computing Rankings

    Addison, TX, Aug. 19, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and legal strategy firm, today announced the release of its Quantum Computing Pulse Report, the first-ever rankings of leadership in the emerging $850B quantum computing market. Designed for investors, board members, and CEOs, the report profiles 38 companies worldwide advancing commercialization through competitive benchmarking and maps the broader intellectual property landscape, drawing on 14,762 patent families to show that leadership is far from settled, with corporate giants competing head to head against concentrated startup portfolios. "Quantum computing has reached a historic inf

    8/19/25 2:30:00 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    MDB Capital Holdings to Host Second Quarter 2025 Update Conference Call on Wednesday August 27, 2025, at 4:30 p.m. Eastern Time

    Addison, TX, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Wednesday August 27, 2025 at 4:30 p.m. Eastern Time to provide a business update for the second quarter 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for the Zoo

    8/14/25 4:35:00 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    HeartBeam Reports Second Quarter 2025 Results

    Executing on Commercial Readiness Plans in Anticipation of FDA 510(k) Clearance for Groundbreaking 12-lead Electrocardiogram (ECG) Synthesis Software Engaged in Ongoing Productive Discussions with FDA Related to the 510(k) Application Increased Business Development Resources to Match Inbound Interest from Industry Partners Management to Host Webcast and Conference Call Today at 4:30 p.m. ET HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, has reported its financial and operational results for the second quarter ended June 30, 2025. Second Quarter & Subsequent 2025 Operational Highligh

    8/13/25 4:01:00 PM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    $BEAT
    $MDBH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Digiandomenico Anthony bought $6,983 worth of shares (1,425 units at $4.90), increasing direct ownership by 2% to 95,699 units (SEC Form 4)

    4/A - MDB Capital Holdings, LLC (0001934642) (Issuer)

    8/8/25 7:09:05 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    Co-Founder Marlett Christopher A bought $442 worth of shares (100 units at $4.42) (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    7/15/25 9:02:05 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    Co-Founder Marlett Christopher A bought $197 worth of shares (44 units at $4.48) (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    6/26/25 5:00:51 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    $BEAT
    $MDBH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Director Digiandomenico Anthony

    4/A - MDB Capital Holdings, LLC (0001934642) (Issuer)

    8/8/25 7:18:26 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    Amendment: Director Digiandomenico Anthony bought $6,983 worth of shares (1,425 units at $4.90), increasing direct ownership by 2% to 95,699 units (SEC Form 4)

    4/A - MDB Capital Holdings, LLC (0001934642) (Issuer)

    8/8/25 7:09:05 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    Co-Founder Marlett Christopher A bought $442 worth of shares (100 units at $4.42) (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    7/15/25 9:02:05 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    $BEAT
    $MDBH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Benchmark initiated coverage on BioTelemetry with a new price target

    Benchmark initiated coverage of BioTelemetry with a rating of Speculative Buy and set a new price target of $9.00

    12/20/21 7:19:06 AM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    $BEAT
    $MDBH
    SEC Filings

    View All

    SEC Form 10-Q filed by MDB Capital Holdings LLC

    10-Q - MDB Capital Holdings, LLC (0001934642) (Filer)

    8/14/25 4:08:48 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    SEC Form 10-Q filed by Heartbeam Inc.

    10-Q - HeartBeam, Inc. (0001779372) (Filer)

    8/13/25 4:02:27 PM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    Heartbeam Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - HeartBeam, Inc. (0001779372) (Filer)

    7/16/25 2:15:18 PM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    $BEAT
    $MDBH
    Financials

    Live finance-specific insights

    View All

    MDB Capital Holdings to Host Second Quarter 2025 Update Conference Call on Wednesday August 27, 2025, at 4:30 p.m. Eastern Time

    Addison, TX, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Wednesday August 27, 2025 at 4:30 p.m. Eastern Time to provide a business update for the second quarter 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for the Zoo

    8/14/25 4:35:00 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    HeartBeam Reports Second Quarter 2025 Results

    Executing on Commercial Readiness Plans in Anticipation of FDA 510(k) Clearance for Groundbreaking 12-lead Electrocardiogram (ECG) Synthesis Software Engaged in Ongoing Productive Discussions with FDA Related to the 510(k) Application Increased Business Development Resources to Match Inbound Interest from Industry Partners Management to Host Webcast and Conference Call Today at 4:30 p.m. ET HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, has reported its financial and operational results for the second quarter ended June 30, 2025. Second Quarter & Subsequent 2025 Operational Highligh

    8/13/25 4:01:00 PM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time

    HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, will hold a conference call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2025, and will be providing updates on regulatory initiatives, commercial-readiness activities and anticipated milestones. A press release detailing these results will be issued prior to the call. HeartBeam CEO Robert Eno and CFO Timothy Cruickshank will host the conference call, followed by a question-and-answer period. The conference call will be accompanied by a presentation, which can be viewed during t

    7/30/25 7:00:00 AM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    $BEAT
    $MDBH
    Leadership Updates

    Live Leadership Updates

    View All

    HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

    Board expansion reflects Company's commitment to leadership and innovation in remote cardiac monitoring HeartBeam, Inc., (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced the appointment of Chief Executive Officer, Robert Eno, to its Board of Directors. As the Company continues to make significant advancements towards commercial readiness, the Board elected to expand from eight to nine members to accommodate this addition. Mr. Eno joined HeartBeam as President in January 2023 and was appointed CEO in October 2024. With over 30 years of experience in the medical technology industry, he has a proven

    5/5/25 7:00:00 AM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

    First cable-free, ambulatory ECG that captures the heart's electrical signals from three distinct directions for high-fidelity data collection and advanced diagnostics Patients can have the credit card-sized device with them at all times, ready to record an ECG whenever they feel symptoms and reduce delays in care Company to initiate Early Access Program to gain important patient and physician feedback on the use of the system in preparation for commercial launch HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that the US Food and Drug Administration (FDA) has granted 510(k) cl

    12/16/24 8:31:00 AM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

    Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and delivering growth Founder and current CEO Branislav Vajdic named President to focus on advancing the Company's groundbreaking vector-based technology for heart health, including AI applications HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful insights wherever the patient is, announced that Robert Eno has been appointed Chief Executive Officer (CEO), effective Monday, October 21, 2024. The seasoned MedTech executive joined HeartBeam as President in January 2023 and will lead as the Company continues to work

    10/17/24 8:31:00 AM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    $BEAT
    $MDBH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Heartbeam Inc.

    SC 13D - HeartBeam, Inc. (0001779372) (Subject)

    10/25/23 4:01:55 PM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by Heartbeam Inc.

    SC 13D - HeartBeam, Inc. (0001779372) (Subject)

    8/28/23 4:26:34 PM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by Heartbeam Inc.

    SC 13D - HeartBeam, Inc. (0001779372) (Subject)

    6/2/23 2:36:13 PM ET
    $BEAT
    Medical/Dental Instruments
    Health Care